Immunosuppressive management following small bowel transplantation

Transplantation Proceedings

Volumn 34, Issue 5, 2002, Pages 1894-1896

  Mueller, A R ^a   Pascher, A ^a   Platz, K P ^a   Nussler N C ^a   Schulz, R J ^a   Junge, G ^a   Klupp, J ^a   Rayes, N ^a   Dignass, A ^a   Radtke, C ^a   Neuhaus, P ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; INTERLEUKIN 2 RECEPTOR ANTIBODY; METRONIDAZOLE; RAPAMYCIN; STEROID; TACROLIMUS; IMMUNOSUPPRESSIVE AGENT;

ADULT; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; GRAFT REJECTION; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INTESTINE TRANSPLANTATION; MUCOSA; PRIORITY JOURNAL; REPERFUSION INJURY; SURVIVAL RATE; ALLOTRANSPLANTATION; ARTICLE; CLASSIFICATION; DRUG COMBINATION; FOLLOW UP; GRAFT SURVIVAL; IMMUNOLOGY; MIDDLE AGED; POSTOPERATIVE COMPLICATION; SMALL INTESTINE; TIME; TRANSPLANTATION; TREATMENT OUTCOME;

ADULT; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE AGENTS; INTESTINE, SMALL; MIDDLE AGE; POSTOPERATIVE COMPLICATIONS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; HUMANS; MIDDLE AGED;

EID: 0035993804     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(02)03113-5     Document Type: Conference Paper

References (11)